The advisory board resolution on the use of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes

The advisory board resolution on the use of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes

Type 2 diabetes is characterized by increasing incidence and prevalence all-over the world. Current therapeutic management of type 2 diabetes is complex and is based not only on glycemic control, but also on cardiovascular and renal risks reduction. In previous years the use of sodium-glucose cotran...

Full description

Saved in:
Bibliographic Details
Main Authors: M. B. Antsiferov, G. R. Galstyan, T. Yu. Demidova, A. V. Zilov, T. N. Markova, А. M. Mkrtumyan, N. A. Petunina, I. S. Khalimov, M. S. Shamkhalova, M. V. Shestakova
Format: Article
Language:English
Published: Endocrinology Research Centre 2023-05-01
Series:Сахарный диабет
Subjects:
type 2 diabetes
sodium-glucose cotransporter 2 inhibitors
glucagon-like peptide 1 receptor agonists
comparability
Online Access:https://www.dia-endojournals.ru/jour/article/view/13034
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items